Cargando…

Performing meta-analysis with incomplete statistical information in clinical trials

BACKGROUND: Results from clinical trials are usually summarized in the form of sampling distributions. When full information (mean, SEM) about these distributions is given, performing meta-analysis is straightforward. However, when some of the sampling distributions only have mean values, a challeng...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jianbing, Liu, Weiru, Hunter, Anthony, Zhang, Weiya
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2571096/
https://www.ncbi.nlm.nih.gov/pubmed/18706124
http://dx.doi.org/10.1186/1471-2288-8-56
_version_ 1782160209194516480
author Ma, Jianbing
Liu, Weiru
Hunter, Anthony
Zhang, Weiya
author_facet Ma, Jianbing
Liu, Weiru
Hunter, Anthony
Zhang, Weiya
author_sort Ma, Jianbing
collection PubMed
description BACKGROUND: Results from clinical trials are usually summarized in the form of sampling distributions. When full information (mean, SEM) about these distributions is given, performing meta-analysis is straightforward. However, when some of the sampling distributions only have mean values, a challenging issue is to decide how to use such distributions in meta-analysis. Currently, the most common approaches are either ignoring such trials or for each trial with a missing SEM, finding a similar trial and taking its SEM value as the missing SEM. Both approaches have drawbacks. As an alternative, this paper develops and tests two new methods, the first being the prognostic method and the second being the interval method, to estimate any missing SEMs from a set of sampling distributions with full information. A merging method is also proposed to handle clinical trials with partial information to simulate meta-analysis. METHODS: Both of our methods use the assumption that the samples for which the sampling distributions will be merged are randomly selected from the same population. In the prognostic method, we predict the missing SEMs from the given SEMs. In the interval method, we define intervals that we believe will contain the missing SEMs and then we use these intervals in the merging process. RESULTS: Two sets of clinical trials are used to verify our methods. One family of trials is on comparing different drugs for reduction of low density lipprotein cholesterol (LDL) for Type-2 diabetes, and the other is about the effectiveness of drugs for lowering intraocular pressure (IOP). Both methods are shown to be useful for approximating the conventional meta-analysis including trials with incomplete information. For example, the meta-analysis result of Latanoprost versus Timolol on IOP reduction for six months provided in [1] was 5.05 ± 1.15 (Mean ± SEM) with full information. If the last trial in this study is assumed to be with partial information, the traditional analysis method for dealing with incomplete information that ignores this trial would give 6.49 ± 1.36 while our prognostic method gives 5.02 ± 1.15, and our interval method provides two intervals as Mean ∈ [4.25, 5.63] and SEM ∈ [1.01, 1.24]. CONCLUSION: Both the prognostic and the interval methods are useful alternatives for dealing with missing data in meta-analysis. We recommend clinicians to use the prognostic method to predict the missing SEMs in order to perform meta-analysis and the interval method for obtaining a more cautious result.
format Text
id pubmed-2571096
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25710962008-11-03 Performing meta-analysis with incomplete statistical information in clinical trials Ma, Jianbing Liu, Weiru Hunter, Anthony Zhang, Weiya BMC Med Res Methodol Research Article BACKGROUND: Results from clinical trials are usually summarized in the form of sampling distributions. When full information (mean, SEM) about these distributions is given, performing meta-analysis is straightforward. However, when some of the sampling distributions only have mean values, a challenging issue is to decide how to use such distributions in meta-analysis. Currently, the most common approaches are either ignoring such trials or for each trial with a missing SEM, finding a similar trial and taking its SEM value as the missing SEM. Both approaches have drawbacks. As an alternative, this paper develops and tests two new methods, the first being the prognostic method and the second being the interval method, to estimate any missing SEMs from a set of sampling distributions with full information. A merging method is also proposed to handle clinical trials with partial information to simulate meta-analysis. METHODS: Both of our methods use the assumption that the samples for which the sampling distributions will be merged are randomly selected from the same population. In the prognostic method, we predict the missing SEMs from the given SEMs. In the interval method, we define intervals that we believe will contain the missing SEMs and then we use these intervals in the merging process. RESULTS: Two sets of clinical trials are used to verify our methods. One family of trials is on comparing different drugs for reduction of low density lipprotein cholesterol (LDL) for Type-2 diabetes, and the other is about the effectiveness of drugs for lowering intraocular pressure (IOP). Both methods are shown to be useful for approximating the conventional meta-analysis including trials with incomplete information. For example, the meta-analysis result of Latanoprost versus Timolol on IOP reduction for six months provided in [1] was 5.05 ± 1.15 (Mean ± SEM) with full information. If the last trial in this study is assumed to be with partial information, the traditional analysis method for dealing with incomplete information that ignores this trial would give 6.49 ± 1.36 while our prognostic method gives 5.02 ± 1.15, and our interval method provides two intervals as Mean ∈ [4.25, 5.63] and SEM ∈ [1.01, 1.24]. CONCLUSION: Both the prognostic and the interval methods are useful alternatives for dealing with missing data in meta-analysis. We recommend clinicians to use the prognostic method to predict the missing SEMs in order to perform meta-analysis and the interval method for obtaining a more cautious result. BioMed Central 2008-08-18 /pmc/articles/PMC2571096/ /pubmed/18706124 http://dx.doi.org/10.1186/1471-2288-8-56 Text en Copyright © 2008 Ma et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ma, Jianbing
Liu, Weiru
Hunter, Anthony
Zhang, Weiya
Performing meta-analysis with incomplete statistical information in clinical trials
title Performing meta-analysis with incomplete statistical information in clinical trials
title_full Performing meta-analysis with incomplete statistical information in clinical trials
title_fullStr Performing meta-analysis with incomplete statistical information in clinical trials
title_full_unstemmed Performing meta-analysis with incomplete statistical information in clinical trials
title_short Performing meta-analysis with incomplete statistical information in clinical trials
title_sort performing meta-analysis with incomplete statistical information in clinical trials
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2571096/
https://www.ncbi.nlm.nih.gov/pubmed/18706124
http://dx.doi.org/10.1186/1471-2288-8-56
work_keys_str_mv AT majianbing performingmetaanalysiswithincompletestatisticalinformationinclinicaltrials
AT liuweiru performingmetaanalysiswithincompletestatisticalinformationinclinicaltrials
AT hunteranthony performingmetaanalysiswithincompletestatisticalinformationinclinicaltrials
AT zhangweiya performingmetaanalysiswithincompletestatisticalinformationinclinicaltrials